Today: 7 February 2026
Subscribe

Swiss Exchange Update (21 Dec 2025): SIX’s SMI Near 13,200 as Holiday Closures Loom and 2026 Forecasts Turn Cautiously Optimistic

Swiss Exchange Update (21 Dec 2025): SIX’s SMI Near 13,200 as Holiday Closures Loom and 2026 Forecasts Turn Cautiously Optimistic

ZURICH — 21 December 2025 — Switzerland’s stock market is heading into the final holiday‑shortened trading stretch of the year with the Swiss Market Index (SMI) still hovering near the upper end of its recent range. The benchmark closed at 13,171.85 on Friday (19 Dec), up 0.27%, with the broader SPI also slightly higher and mid-caps mixed, according to SIX market data. SIX That’s the headline number investors will carry into year‑end positioning — but the more interesting story is the one behind the tape: SIX Swiss Exchange is closing 2025 after a year of record turnover milestones, product‑market tweaks
21 December 2025
São Paulo Stock Exchange (B3) Update on Dec. 21, 2025: Ibovespa Ends Week at 158,473 as 2026 Forecasts Reach 250,000

São Paulo Stock Exchange (B3) Update on Dec. 21, 2025: Ibovespa Ends Week at 158,473 as 2026 Forecasts Reach 250,000

São Paulo — Dec. 21, 2025. The São Paulo Stock Exchange—officially B3 (Brasil, Bolsa, Balcão)—heads into a holiday-shortened stretch with a familiar mix of late-year ingredients: thinner liquidity, louder politics, and analysts turning the dial from “what just happened?” to “what could 2026 look like?” The headline number: the Ibovespa finished the week at 158,473.02 points, down 1.43% from the prior week’s 160,766.37, according to a weekly wrap from Estadão’s E-Investidor. Estadão E-Investidor But the more interesting story on Dec. 21 isn’t the last tick—it’s the range of expectations being published for 2026: big banks and brokerages are floating targets
21 December 2025
Australian Securities Exchange (ASX) in Focus: ASIC’s $150m Capital Charge, CHESS Replacement Milestones, and the ASX 200 Outlook Into 2026

Australian Securities Exchange (ASX) in Focus: ASIC’s $150m Capital Charge, CHESS Replacement Milestones, and the ASX 200 Outlook Into 2026

SYDNEY — 21 December 2025 — Australia’s financial markets are heading into the final trading stretch of the year with the Australian Securities Exchange (ASX) under unusually bright floodlights: regulators have imposed a significant additional capital requirement on the ASX operator, demanded sharper governance and accountability across clearing and settlement, and effectively tied future “business as usual” to demonstrable technology resilience. ASIC+2Reuters+2 At the same time, the broader sharemarket — often casually called “the ASX” by investors — is trying to navigate a familiar end‑of‑year cocktail: thinner liquidity, “Santa rally” speculation, global tech volatility, commodity cross‑currents, and an interest‑rate debate
21 December 2025
··
Euronext News and Forecast (Dec. 21, 2025): Consolidated Tape Momentum, Post‑Trade Expansion, and What Analysts Expect for ENX in 2026

Euronext News and Forecast (Dec. 21, 2025): Consolidated Tape Momentum, Post‑Trade Expansion, and What Analysts Expect for ENX in 2026

Euronext (ENX.PA) is having a very “market-structure” kind of month—the sort of news cycle that doesn’t scream in neon, but quietly decides how European capital markets work (and who gets paid) for years. As of Sunday, December 21, 2025, the pan-European exchange group is sitting at the intersection of three big themes investors keep circling back to: Below is a detailed, publication-ready roundup of the latest news, forecasts, and market analysis shaping the Euronext story right now. The week in Euronext: why December 2025 matters If you’re trying to “read” Euronext’s playbook, a simple translation helps: This week’s headlines line
21 December 2025
·
Korea Exchange (KRX) Update Dec. 21, 2025: Fee Cuts Squeeze Nextrade, Delisting Push Meets Courts, and KOSPI 5,000 Forecasts for 2026

Korea Exchange (KRX) Update Dec. 21, 2025: Fee Cuts Squeeze Nextrade, Delisting Push Meets Courts, and KOSPI 5,000 Forecasts for 2026

SEOUL — December 21, 2025 — The Korea Exchange (KRX), operator of South Korea’s main equity markets including KOSPI and KOSDAQ, is heading into year-end with a rare mix of momentum and stress tests: a roaring 2025 rally, intensifying competition from the alternative trading system Nextrade (NXT), and a regulatory drive to clean out “zombie” listings that’s colliding with court delays. Global KRX+2AJU PRESS+2 Today’s headlines paint a picture of a market infrastructure that’s modernizing fast—but discovering that the hardest part of reform isn’t writing new rules. It’s making the whole ecosystem (brokers, courts, issuers, investors, and rival venues) move
21 December 2025
·
Singapore Exchange (SGX) Update on Dec 21, 2025: STI Rally, REIT Inflows, Nasdaq Dual-Listing Bridge and 2026 Forecasts

Singapore Exchange (SGX) Update on Dec 21, 2025: STI Rally, REIT Inflows, Nasdaq Dual-Listing Bridge and 2026 Forecasts

SINGAPORE — The Singapore Exchange (SGX) heads into the final stretch of 2025 with something it hasn’t consistently enjoyed in recent years: momentum that’s visible in both price action and participation—and a policy-and-product agenda that’s clearly designed to make that momentum harder to reverse. With seven trading days left in 2025, the Straits Times Index (STI) has delivered a year-to-date price return of 20.7% (as of Dec 18), while Singapore REITs (S-REITs) are up 9% over the same period. Meanwhile, 10 S-REITs have attracted more than S$1 billion in combined net retail inflows year to date—an attention-grabbing datapoint in a
21 December 2025
New York Stock Exchange (NYSE) Update: Holiday Trading Week, New Listing Rules, and What Markets Are Watching on Dec. 21, 2025

New York Stock Exchange (NYSE) Update: Holiday Trading Week, New Listing Rules, and What Markets Are Watching on Dec. 21, 2025

NEW YORK — December 21, 2025 — The New York Stock Exchange heads into Christmas week with three storylines converging at once: a holiday-shortened trading calendar, fresh regulatory filings that reshape parts of the NYSE rulebook, and a market still debating whether a “Santa Claus rally” can show up on schedule after a choppy December. Investopedia+2Reuters+2 For investors, the practical focus is simple: liquidity tends to thin out, headline risk tends to feel bigger, and a handful of delayed U.S. economic releases now carry extra weight. For issuers and listing advisers, the focus is more structural: NYSE is tightening continued-listing
21 December 2025
·
National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

National Stock Exchange of India (NSE) Update: Record-Low India VIX, Derivatives Rule Changes, and IPO Watch as 2025 Ends

Mumbai/Bengaluru — December 21, 2025 — The National Stock Exchange of India (NSE) is ending 2025 in a situation that would have sounded contradictory a few years ago: India is home to one of the biggest derivatives machines on Earth, yet the country’s flagship equity market is behaving like it’s on sedatives. Options traders are being forced to rethink playbooks, regulators are still tightening the screws on speculation, and the exchange itself remains in the spotlight for a long-awaited IPO that’s still gated by settlements and governance clean-up. Because December 21, 2025 is a Sunday (markets are shut), the day’s
21 December 2025
·
Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology Stocks Week Ahead (Dec. 22–26, 2025): BioMarin–Amicus Deal, Cytokinetics FDA Win, IPO Filings, and Drug-Price Policy Risks

Biotechnology stocks head into the Christmas-shortened trading week with fresh momentum—and plenty for investors to digest—after a dense run of catalysts between December 19 and December 21, 2025. In the span of 48 hours, the sector saw a major rare-disease acquisition, a closely watched FDA approval in cardiology, IPO paperwork from both biotech and medtech, and a sweeping wave of U.S. drug-pricing headlines that could reshape sentiment into 2026. Investopedia+4Reuters+4Reuters+4 The setup matters because next week’s market structure will be unusual: U.S. stock markets are scheduled to close early on Wednesday, December 24 (1:00 p.m. ET) and remain closed on
21 December 2025
·····
Pharma Stocks Week Ahead (Dec. 22–26, 2025): Drug-Pricing Deals, FDA Catalysts, and M&A to Watch

Pharma Stocks Week Ahead (Dec. 22–26, 2025): Drug-Pricing Deals, FDA Catalysts, and M&A to Watch

Christmas week is usually about thin liquidity and shorter trading hours, not blockbuster headlines. But pharma and biotech stocks head into the final full week of the year with a rare mix of policy shockwaves, deal-making, and FDA-driven volatility—all clustered around Dec. 19–21, 2025. From the White House’s sweeping “most-favored-nation” (MFN) push on U.S. drug prices to BioMarin’s largest-ever acquisition and fresh FDA approvals, the setup into year-end has become more headline-sensitive than the calendar would suggest. Here’s what investors and traders should be watching in pharma stocks in the week ahead. Christmas week trading: shorter sessions, fewer buyers, faster
21 December 2025
·········
Bombay Stock Exchange Today: Sensex at 84,929, Major BSE Index Rejig on Dec 22, and What to Watch in the Christmas Week (21 December 2025)

Bombay Stock Exchange Today: Sensex at 84,929, Major BSE Index Rejig on Dec 22, and What to Watch in the Christmas Week (21 December 2025)

Mumbai | 21 December 2025 — The Bombay Stock Exchange (BSE) heads into a holiday-thinned, event-heavy week with a familiar cocktail: a late rebound in benchmarks, a looming BSE index reshuffle that can force passive-fund flows, and a fresh exchange-level proposal aimed at curbing “too many orders, not enough trades” behavior in the cash market. Since Sunday is a non-trading day, the freshest price signals come from Friday’s close (19 December 2025)—and the message there was cautiously upbeat: the BSE Sensex rose 0.53% to 84,929.36, while the Nifty 50 gained 0.58% to 25,966.40, snapping a four-day losing streak. NDTV Profit+1
21 December 2025
··
Nuclear Stocks Week Ahead (Dec 22–26, 2025): Uranium Near $80, Centrus Fuel-Chain Catalyst, and SMR Volatility in Focus

Nuclear Stocks Week Ahead (Dec 22–26, 2025): Uranium Near $80, Centrus Fuel-Chain Catalyst, and SMR Volatility in Focus

Nuclear stocks head into the Christmas week with two forces pulling in opposite directions: a holiday-thinned trading calendar that can exaggerate moves, and a still-bullish long-term narrative tied to grid reliability, AI data center power demand, and government-backed “reshoring” of the nuclear fuel cycle. New York Stock Exchange+2Investopedia+2 Across Dec. 19–21, 2025, the story wasn’t a single headline—it was a cluster of catalysts: uranium holding near the psychologically important $80/lb area, fresh “uranium renaissance” commentary around forward pricing, a major enrichment supply-chain update from Centrus Energy (LEU), renewed debate over small modular reactor (SMR) names like Oklo (OKLO) and NuScale
21 December 2025
··
Space & Satellite Tech Stocks Week Ahead: Rocket Lab’s $816M Space Force Win, AST SpaceMobile’s BlueBird 6 Launch, and EchoStar’s Spectrum Spotlight

Space & Satellite Tech Stocks Week Ahead: Rocket Lab’s $816M Space Force Win, AST SpaceMobile’s BlueBird 6 Launch, and EchoStar’s Spectrum Spotlight

Holiday-shortened trading weeks can be deceptively eventful for space and satellite tech stocks: lower liquidity tends to amplify moves, while “hard” catalysts like contract awards, launch milestones, and regulatory headlines still land on the tape. Heading into the week of Dec. 22–26, 2025, investors are digesting a tightly packed stream of headlines and fresh analyst takes published Dec. 19–21—with Rocket Lab (RKLB), AST SpaceMobile (ASTS), Intuitive Machines (LUNR), EchoStar (SATS), and Planet Labs (PL) among the most-discussed names. Below is what moved the group over Dec. 19–21, 2025, and what to watch next as space and satellite stocks set up
21 December 2025
······
Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

Military Tech Stocks Week Ahead (Dec. 22–26, 2025): Space Force Satellite Awards, Drone Dominance, and Analyst Calls in Focus

Military tech stocks are heading into the Christmas-shortened trading week with fresh catalysts from December 19–21 that reinforce a clear narrative: modern defense spending is tilting toward space-based sensing, low-cost drones, and software-heavy systems—while investors debate how much of that shift is already priced into 2025’s big gains. Barron’s+3Air & Space Forces Magazine+3Reuters+3 With U.S. equity markets set to close early on Wednesday, December 24, and remain closed on Thursday, December 25, any headlines on contracts, policy, or analyst calls can have an outsized impact in thinner liquidity—especially for smaller-cap “pure-play” defense tech names. Investopedia+2New York Stock Exchange+2 Below is
21 December 2025
······
Data Center Stocks Week Ahead: AI Capex Scrutiny, Power Constraints, and Holiday Trading Put Nvidia, Vertiv, and Data Center REITs in Focus

Data Center Stocks Week Ahead: AI Capex Scrutiny, Power Constraints, and Holiday Trading Put Nvidia, Vertiv, and Data Center REITs in Focus

Data center stocks head into the week of December 22, 2025 at an unusual intersection: the AI infrastructure buildout is still accelerating, but markets are getting far less forgiving about how it’s funded, how quickly it pays back, and whether the power grid can keep up. That tension was on full display from December 19–21—a three-day stretch that brought fresh evidence of a global data center construction wave, rising regulatory and political pushback on electricity costs, and renewed questions about the sustainability of debt-heavy AI expansion. At the same time, parts of the AI trade bounced late in the week
21 December 2025
·
Software and Platform Stocks Week Ahead: AI Spending Scrutiny, Cloud Security Mega-Deals, and Holiday-Shortened Trading (Dec. 22–26, 2025)

Software and Platform Stocks Week Ahead: AI Spending Scrutiny, Cloud Security Mega-Deals, and Holiday-Shortened Trading (Dec. 22–26, 2025)

Dec. 21, 2025 — Software and platform stocks head into the Christmas week balancing two powerful forces: a thinner, holiday-shortened market that can amplify price swings, and a still-evolving narrative around the AI buildout—specifically, when massive infrastructure spending turns into measurable profits. By Friday’s close, investors were once again talking about a potential “Santa Claus rally,” but the setup feels different than in a typical year. The sector’s winners are increasingly defined by platform leverage (cloud ecosystems, cybersecurity suites, and data/AI tooling) rather than simple “growth at any price.” At the same time, several high-growth SaaS names face tougher comparisons
21 December 2025
········
Toronto Stock Exchange (TSX) Today: S&P/TSX Composite Hits a Record High, Holiday Trading Hours, and 2026 Forecasts — Dec. 21, 2025

Toronto Stock Exchange (TSX) Today: S&P/TSX Composite Hits a Record High, Holiday Trading Hours, and 2026 Forecasts — Dec. 21, 2025

TORONTO — Bay Street is heading into the Christmas-shortened trading week with the kind of momentum that makes both optimists and risk managers feel uncomfortably alive. On Friday, Canada’s benchmark S&P/TSX Composite Index closed at 31,755.77, up 1% on the day, in heavy volume—a fresh record close that capped a choppy but ultimately positive pre-holiday stretch. The index finished the week up 0.7%, and it has gained 28.4% year-to-date, putting 2025 on track for its biggest annual advance since 2009. Reuters As of Sunday, Dec. 21, 2025, that backdrop sets up a very TSX-flavored storyline: commodities and financials remain the
21 December 2025
·
Bank Stocks Week Ahead: Fed “Pause” Signals, Holiday-Thin Trading, and Buybacks Put Financials in Focus (Dec. 22–26, 2025)

Bank Stocks Week Ahead: Fed “Pause” Signals, Holiday-Thin Trading, and Buybacks Put Financials in Focus (Dec. 22–26, 2025)

Bank stocks head into Christmas week with a familiar year-end setup: lighter liquidity, a compressed calendar, and just enough macro and policy headlines to move interest rates—and, by extension, the entire financial sector. Over Dec. 19–21, 2025, the storylines that matter most for banks crystallized quickly: Federal Reserve officials pushed back on near-term rate-cut urgency, a fresh batch of delayed U.S. data is finally set to hit the tape, and banks on both sides of the Atlantic kept returning cash to shareholders through buybacks while dealmaking and trading revenues stayed in focus. Reuters+4Reuters+4Reuters+4 Below is what bank-stock investors and financials
21 December 2025
Renewable Energy Stocks Week Ahead: Offshore Wind Wins, Grid Spending, and Data‑Center Power Demand in Focus (Dec 22–26, 2025)

Renewable Energy Stocks Week Ahead: Offshore Wind Wins, Grid Spending, and Data‑Center Power Demand in Focus (Dec 22–26, 2025)

Renewable energy stocks head into the Christmas week with a familiar mix of tailwinds and tripwires: supportive long-duration contracts in Europe, rising investment in grids and interconnectors, and a fast-evolving “power race” driven by data centers—set against the usual year-end liquidity drop and rate sensitivity that can exaggerate moves. The latest news and analysis from December 19–21, 2025 reinforces one central message for investors: the renewables trade is becoming less about ideology and more about system build‑out—generation, storage, and the wires in between. That shift matters because it changes which sub-sectors can outperform in a low-liquidity holiday week: typically, the
21 December 2025
·
Oil and Gas Stocks Week Ahead: Crude Near $60, Venezuela Crackdown Risks, and an EIA Data Delay Reset the Energy Trade

Oil and Gas Stocks Week Ahead: Crude Near $60, Venezuela Crackdown Risks, and an EIA Data Delay Reset the Energy Trade

Oil and gas stocks head into the Christmas week with a familiar tug-of-war: prices are being pulled down by swelling supply and “oil on water” inventory signals, yet pushed up by fast-moving geopolitical headlines—especially around Venezuela—and rising scrutiny of “shadow” shipping routes. As of Friday, December 19, Brent settled at $60.47 a barrel and U.S. WTI at $56.66, with markets still finishing the week lower even after a late bounce tied to Venezuela and Russia-Ukraine developments. Reuters For investors, the week ahead is less about earnings (quiet) and more about headline risk, inventory transparency, and positioning—with a notable twist: the
21 December 2025
1 … 815 816 817 818 819 … 1,632

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop